IR News

2022

• 2022.12.19
  Q&A Summary for CEO Presentation in November 2022(PDF : 136KB)
• 2022.12.13Mitsui Chemicals Included on Dow Jones Sustainability Indices Asia Pacific for Five Straight Year
• 2022.12.05Video Recording of CEO presentation in November 2022
• 2022.12.01
  Notice regarding Status of Repurchase of Own Shares(PDF : 89.2KB)
• 2022.11.30Mitsui Chemicals Wins Two Awards as Part of WICI Japan Integrated Report Award 2022
• 2022.11.28
  FY22-2 CEO Presentation(PDF : 3.3MB)
• 2022.11.24Mitsui Chemicals Receives Best IR Award From Japan Investor Relations Association
• 2022.11.22
  Questions from the Internet Briefing for Institutional Investors and Analysts on Mitsui Chemicals Group’s Consolidated Financial Results for 2nd Quarter of Fiscal 2022(PDF : 141.9KB)
• 2022.11.11Video Recording of the Internet Briefing on Mitsui Chemicals Group’s Consolidated Financial Results for 2nd Quarter of Fiscal 2022
• 2022.11.08
  Notice regarding Repurchase and Cancellation of Own Shares(PDF : 93.2KB)
• 2022.11.08
  Summary of Consolidated Financial Results for Second Quarter of FY2022(PDF : 334.5KB)
• 2022.11.08
  Financial Summary - Results for 1st Half of FY2022 & Outlook for FY2022(PDF : 676.1KB)
• 2022.10.19Mitsui Chemicals Selected by Securities Analysts to Receive 2022 Award for Excellence in Corporate Disclosure
• 2022.08.30Mitsui Chemicals to Build New TAFMER™ Plant in Singapore
• 2022.08.26
  Mitsui Chemicals to Transfer Shareholding in Mitsui Phenols Singapore Pte. Ltd. to INEOS Holdings Limited(PDF : 130.1KB)
• 2022.08.05
  Summary of Consolidated Financial Results for First Quarter of FY2022(PDF : 581.7KB)
• 2022.08.05
  Financial Summary - Results for First Quarter of FY2022 & Outlook for FY2022(PDF : 592.8KB)
• 2022.08.05
  Notice for Revisions of Financial Forecasts(PDF : 75.4KB)
• 2022.07.22
  Completion of Payment for Issuance of New Shares as Restricted Stock Compensation(PDF : 86.7KB)
• 2022.06.27
  Voting Results of the 25th Ordinary General Meeting of Shareholders(PDF : 92.4KB)
• 2022.06.24
  Detailed Consolidated Financial Statements(PDF : 1.9MB)
• 2022.06.24
  Issuance of New Shares as Restricted Stock Compensation(PDF : 141.6KB)
• 2022.06.22Mitsui Chemicals starts implementing IBM Watson for New Application Discovery Advancing DX for Sales Domain by Utilizing Big Data and AI
• 2022.06.02
  FY22-1 CEO Presentation(PDF : 3.7MB)
• 2022.05.30
  Convocation Notice for the 25th Ordinary General Meeting of Shareholders(PDF : 370KB)
• 2022.05.27Mitsui Chemicals to Acquire Pellicle Business From Asahi Kasei
• 2022.05.13
  Summary of Consolidated Financial Results for FY2021(PDF : 956.8KB)
• 2022.05.13
  Financial Summary - Results for FY2021 & Outlook for FY2022(PDF : 635.9KB)
• 2022.05.13
  Notice Regarding the Recording of Impairment Loss and Loss on Valuation of Shares of Subsidiaries and Affiliates(PDF : 39.9KB)
• 2022.03.08Mitsui Chemicals Acquires Stake in NATiAS and Agrees Business Alliance
• 2022.02.03
  Summary of Consolidated Financial Results for Third Quarter of FY2021(PDF : 829.6KB)
• 2022.02.03
  Financial Summary - Results for Third Quarter of FY2021 & Outlook for FY2021(PDF : 594.8KB)
• 2022.02.03
  Notice for Revisions of Dividend Forecast(PDF : 41KB)
• 2022.01.28Mitsui Chemicals Receives Highest Rating for Employee Health Management from the Development Bank of Japan
• 2022.01.14Announcement of personnel changes